Changzhou Qianhong Biopharma Co Ltd (002550) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

Based on the latest financial reports, Changzhou Qianhong Biopharma Co Ltd (002550) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥156.34 Million ≈ $22.88 Million USD) by net assets (CN¥2.76 Billion ≈ $403.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Changzhou Qianhong Biopharma Co Ltd (002550) liquidity interval to measure how many days the company can operate on defensive assets alone.

Changzhou Qianhong Biopharma Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Changzhou Qianhong Biopharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Changzhou Qianhong Biopharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Changzhou Qianhong Biopharma Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
SFL Corporation Ltd
NYSE:SFL
0.067x
Shandong Intco Recycling Resources Co Ltd
SHG:688087
0.064x
Jiangsu Seagull Cooling Tower
SHG:603269
0.232x
Sino Prima Gas Technology Co Ltd
SHE:300483
0.136x
Shanghai Fortune Techgroup Co Ltd
SHE:300493
0.105x
Shen Ma Industry Co Ltd
SHG:600810
0.024x
Mercialys SA
PA:MERY
0.084x
Old Second Bancorp Inc
NASDAQ:OSBC
0.041x

Annual Cash Flow Conversion Efficiency for Changzhou Qianhong Biopharma Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Changzhou Qianhong Biopharma Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Changzhou Qianhong Biopharma Co Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.77 Billion
≈ $404.78 Million
CN¥361.36 Million
≈ $52.88 Million
0.131x -36.13%
2024-12-31 CN¥2.52 Billion
≈ $368.25 Million
CN¥514.71 Million
≈ $75.32 Million
0.205x -5.13%
2023-12-31 CN¥2.47 Billion
≈ $362.01 Million
CN¥533.33 Million
≈ $78.04 Million
0.216x +833.97%
2022-12-31 CN¥2.43 Billion
≈ $356.08 Million
CN¥-71.47 Million
≈ $-10.46 Million
-0.029x -160.08%
2021-12-31 CN¥2.12 Billion
≈ $309.95 Million
CN¥103.56 Million
≈ $15.15 Million
0.049x -68.17%
2020-12-31 CN¥2.07 Billion
≈ $302.24 Million
CN¥317.28 Million
≈ $46.43 Million
0.154x +121.81%
2019-12-31 CN¥2.33 Billion
≈ $341.34 Million
CN¥161.55 Million
≈ $23.64 Million
0.069x +590.82%
2018-12-31 CN¥2.54 Billion
≈ $371.42 Million
CN¥25.45 Million
≈ $3.72 Million
0.010x -72.22%
2017-12-31 CN¥2.45 Billion
≈ $358.94 Million
CN¥88.52 Million
≈ $12.95 Million
0.036x -60.41%
2016-12-31 CN¥2.42 Billion
≈ $354.79 Million
CN¥221.01 Million
≈ $32.34 Million
0.091x -27.00%
2015-12-31 CN¥2.29 Billion
≈ $335.75 Million
CN¥286.50 Million
≈ $41.92 Million
0.125x +5.67%
2014-12-31 CN¥2.13 Billion
≈ $312.08 Million
CN¥252.01 Million
≈ $36.88 Million
0.118x +45.10%
2013-12-31 CN¥1.97 Billion
≈ $288.35 Million
CN¥160.47 Million
≈ $23.48 Million
0.081x -23.84%
2012-12-31 CN¥1.87 Billion
≈ $273.47 Million
CN¥199.82 Million
≈ $29.24 Million
0.107x +28.62%
2011-12-31 CN¥1.77 Billion
≈ $258.44 Million
CN¥146.82 Million
≈ $21.48 Million
0.083x -79.94%
2010-12-31 CN¥413.78 Million
≈ $60.55 Million
CN¥171.51 Million
≈ $25.10 Million
0.415x +1109.63%
2009-12-31 CN¥243.68 Million
≈ $35.66 Million
CN¥8.35 Million
≈ $1.22 Million
0.034x -86.26%
2008-12-31 CN¥217.99 Million
≈ $31.90 Million
CN¥54.36 Million
≈ $7.95 Million
0.249x +46.60%
2007-12-31 CN¥211.61 Million
≈ $30.97 Million
CN¥35.99 Million
≈ $5.27 Million
0.170x --

About Changzhou Qianhong Biopharma Co Ltd

SHE:002550 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.10 Billion
CN¥7.49 Billion CNY
Market Cap Rank
#8682 Global
#2156 in China
Share Price
CN¥5.85
Change (1 day)
+1.21%
52-Week Range
CN¥5.78 - CN¥12.27
All Time High
CN¥12.27
About

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addit… Read more